Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
Kraushaar
K J
KJ
Consumer Healthcare Products Association (CHPA), Washington, D.C., USA
D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D016568:Drugs, Generic; D004465:Economic Competition; D006801:Humans; D008389:Marketing of Health Services; D004366:Nonprescription Drugs; D011356:Product Labeling / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D004366:Nonprescription Drugs